Records containing: Iris Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-02A Proof of Concept Study of TBio-4101 (an Autologous Selected and Expanded Tumor Infiltrating Lymphocyte [TIL] Therapy) Using Short-Term Cultured, Selected Autologous TIL Following a Lymphodepleting Chemotherapy Regimen and Followed by IL-2 for Patients With Relapsed or Refractory Melanoma (Phase 1)
-
CLINICAL_TRIALS study record update · 2026-03-16A Randomized Phase ll Study of Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma
-
CLINICAL_TRIALS study record update · 2018-10-29Adjuvant Therapy for Patients With Primary Uveal Melanoma With Genetic Imbalance
-
CLINICAL_TRIALS study record update · 2017-05-18Randomized Phase II Trial of Temozolomide Versus Hyd-Sulfate AZD6244 [NSC 748727] in Patients With Metastatic Uveal Melanoma
-
CLINICAL_TRIALS study record update · 2016-03-11Prophylactic Hepatic Irradiation for Uveal Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-03-10Pilot Study of Sequential Hepatic Radioembolization and Systemic Ipilimumab in Patients With Uveal Melanoma Metastatic to Liver
-
CLINICAL_TRIALS study record update · 2015-07-20Phase II Study of IMC-A12 in Metastatic Uveal Melanoma
-
CLINICAL_TRIALS study record update · 2015-06-23A Phase II Study of AZD2171 in Previously Untreated Patients With Metastatic or Recurrent Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2015-04-15A Randomized Phase II Continuation Booster Trial After A Vaccine Combining Tyrosinase/GP100/Mart-1 Peptides Emulsified With Montanide ISA 51 and ISA 51 VG With Or Without GM-CSF For Patients With Resected Stages IIB/C, III And IV Melanoma
-
CLINICAL_TRIALS study record update · 2015-02-04A Phase 2 Study Evaluating the Efficacy of VEGF Trap in Patients With Recurrent Inoperable Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2014-10-03A Phase II Study of Vorinostat in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2014-08-12A Randomized, Placebo-Controlled Phase III Trial of Yeast Derived GM-CSF Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With "No Evidence of Disease" After Complete Surgical Resection of "Locally Advanced" and/or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2014-05-22A PHASE II TRIAL OF A VACCINE COMBINING MULTIPLE CLASS I PEPTIDES WITH MONTANIDE ISA 51 OR ISA 51 VG AND CpG ADJUVANT 7909 FOR PATIENTS WITH RESECTED STAGES IIC/III AND IV MELANOMA
-
CLINICAL_TRIALS study record update · 2013-03-05A Phase II Trial of PS-341 in Combination With Paclitaxel and Carboplatin for the Treatment of Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-07-11Phase II Trial of BAY 43-9006 (Sorafenib; NSC-724772) in Combination With Carboplatin and Paclitaxel in Patients With Metastatic Uveal Melanoma